Effects & safety
Melanotan 2 Effects: What People Report, and What the Safety Literature Documents
The reported upsides, the reported downsides, and the cited harms — kept separate and stated plainly.
The short version
People use Melanotan 2 mainly to get a deep tan with little sun. They also report less appetite and, in men, a strong rise in sex drive and spontaneous erections. Those are the effects that draw people in. But the same activity produces a long list of downsides: nausea, facial flushing, fatigue, darkening of existing moles, and — most worryingly — brand-new moles appearing during use.
The section below separates two very different kinds of information. First, what people report — these are community accounts, anecdotal and not from controlled trials. Second, safety and cautions — these are grounded in published case reports and studies, and each is cited. The reported effects tell you what users notice; the safety section tells you what the medical literature has documented, including serious harms like melanoma, kidney injury, and prolonged painful erections.
What people report
The following are effects described by people in the research-use and tanning community. They are anecdotal, not clinical evidence, are not verified by controlled trials, and no doses are given here. They are included so readers understand what is actually reported — the appeal and the downsides alike.
Reported benefits
- A rapid, deep tan with little or no sun. This is very commonly described as the whole reason people seek it out — skin darkening noticeably within days, reaching a deeper color with far less time in the sun or on a sunbed.
- Cosmetic satisfaction and confidence. Many say they feel more attractive with the tan and keep using it for that reason. Some discussions note this can shade into preoccupation with appearance.
Reported mixed effects (welcomed by some, unwanted by others)
- Reduced appetite and weight loss. Very commonly reported, often from the first dose — feeling much less hungry, sometimes within the hour, with some reporting weight loss.
- Increased libido and spontaneous erections (men). Commonly reported by men, often from the first or second use — a sudden surge in sex drive and unprompted erections, sometimes at inconvenient times. Some welcome it; others find it uncomfortable. Women also report heightened arousal.
- Spontaneous stretching and yawning. A distinctive, frequently mentioned urge to stretch and yawn repeatedly after a dose — described as odd but harmless.
- A belief that the darker tan protects against burning. Some treat their deeper color as a safety upside. This is a user belief, not demonstrated protection, and many still report burning when they overdo sun exposure.
Reported adverse effects
- Nausea, sometimes vomiting. One of the most consistently described effects, typically in the first hour after a dose and worst in the early days, easing as people continue.
- Facial flushing and feeling hot, usually within minutes to an hour of a dose.
- Darkening of existing moles and freckles, very commonly reported and often the first visible sign of activity, with spots standing out more sharply than the surrounding skin.
- Appearance of new moles — a frequent and alarming report among longer-term users, sometimes many at once, which is often what prompts a doctor visit.
- Darkening of face, lips, scars, gums, and genital skin, which can look conspicuous; some describe new facial patches resembling melasma.
- Fatigue and lethargy — a run-down, flu-like feeling early in use that many call the "melanotan flu."
- Injection-site reactions — redness, swelling, itching, bruising, or small lumps, usually described as minor.
- Uneven, blotchy, or unnaturally long-lasting tan, sometimes with an orange or grey cast, and color that lingers for weeks to months — fading slowly and patchily after stopping, with moles sometimes staying darker than before.
Melanotan 2 reviews
Independent academic work has actually catalogued these self-reports. A qualitative study of online discussion forums analyzed how people describe their Melanotan 2 use, mapping the gap between what they expect and what they experience [22]. A separate analysis of social-media marketing and perceptions of the so-called "Barbie drug" documented how the tan is promoted versus the documented risk [12]. The pattern across both is consistent with the community reports above: tanning and appetite/libido effects pull people in, while nausea, mole changes, and the unregulated nature of the product are the recurring complaints. These remain reported experiences and qualitative findings — not controlled efficacy data.
Is melanotan 2 safe
Safety & cautions — each point below is grounded in the published literature and cited.
New, changing, or darkening moles and melanoma risk. As a non-selective melanocortin agonist acting on MC1R, Melanotan 2 drives melanocyte activity throughout the skin. Case reports describe eruptive new nevi, dysplastic (atypical) moles, and darkening of existing moles after use [13], [14], [15], [16], dermoscopy studies show measurable changes in melanocytic lesions during use [17], and several reports document melanoma and melanoma in situ arising in users [18], [19], [20], [21], [23]. A causal link to melanoma is not proven, but it is a serious case-reported concern — especially with concurrent UV or sunbed exposure. Any new or changing mole during or after use warrants prompt dermatological assessment.
Rhabdomyolysis and acute kidney injury. A published case links Melanotan 2 injection to systemic toxicity with rhabdomyolysis — severe muscle breakdown [24] — and a separate case and literature review describe renal infarction associated with its use [4]. The mechanisms are not fully understood and may relate to the peptide's effects on blood vessels.
Priapism (prolonged, painful erection). Because melanocortin agonism promotes erections, several case reports describe priapism following melanotan tanning injections, including after apparent overdose [25], [26], [27]. Priapism is a urological emergency that can permanently damage erectile tissue if not treated quickly.
Posterior reversible encephalopathy syndrome (PRES). A case report describes PRES — a neurological condition involving brain swelling that can present with headache, seizures, visual disturbance, and high blood pressure — in association with melanotan use [28], consistent with the compound's reported effects on blood pressure.
Nausea and cardiovascular (pressor) effects. Preclinical work on the hemodynamics of alpha-MSH analogs shows melanocortin agonists can raise blood pressure [29], and animal studies indicate this pressor effect is worsened by impaired nitric-oxide signaling [30]. Together with very commonly reported nausea — which was severe in roughly 13% of subjects at the doses used in controlled studies [31] — this points to meaningful cardiovascular and gastrointestinal effects that are poorly characterized in humans using unregulated product.
Unregulated product: contamination, mislabeling, and unknown content. Analytical studies of Melanotan 2 bought online repeatedly find inaccurate labeling, variable or unverifiable peptide content, and impurities [32], [33], and the compound appears in surveys of falsified and black-market injectables [34], [35]. Because there is no quality control, a buyer cannot know the actual identity, dose, purity, or sterility of what is in the vial [36], [37], which compounds every other risk.
No regulatory approval and unknown long-term safety. Melanotan 2 has never been approved for any use, and development never completed late-phase trials, so its long-term safety in humans is unknown [3], [38]. Regulators and dermatology bodies have specifically warned against melanotan tanning products [36], [37].
Melanotan 2 dangers in one place
The most serious documented dangers, drawn from the cited record above, are: melanoma and melanoma in situ in users [18], [19], [20], [21], [23]; renal infarction [4] and rhabdomyolysis with kidney injury [24]; priapism requiring emergency care [25], [26], [27]; PRES [28]; and the across-the-board uncertainty that comes from injecting an unregulated, often mislabeled product [32], [33]. None of these is a routine cosmetic side effect — they are reasons the medical literature treats Melanotan 2 as a hazardous, unapproved research chemical rather than a tanning product.
Then and now
Melanotan 2 was designed in the late 1980s at the University of Arizona as a superpotent cyclic analog of the natural pigment hormone alpha-MSH, intended to promote tanning and photoprotection and so potentially reduce skin-cancer risk [3]. Early human work included the pilot Phase I tanning study [1] and, after researchers noticed it also triggered erections, a small study in men with erectile dysfunction [2] and the development of a spin-off agonist for sexual dysfunction [39]. The original tanning program never reached the market. From the mid-2000s an illicit trade emerged, with the peptide sold online as unlicensed "sun-tan jabs" or the "Barbie drug" despite repeated warnings from regulators and dermatologists [40], [12]. It remains an unapproved research chemical with no sanctioned medical or cosmetic use [3].